A STUDY TO EVALUATE THE EFFICACY AND SAFETY OF DARATUMUMAB IN COMBINATION WITH CYCLOPHOSPHAMIDE, BORTEZOMIB AND DEXAMETHASONE (CYBORD) COMPARED TO CYBORD ALONE IN NEWLY DIAGNOSED SYSTEMIC AMYLOID LIGHT-CHAIN (AL) AMYLOIDOSIS: